Dr. Spielberg is a specialized oncohematologist treating patients at Assuta Medical Center.
Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.
Dr. Zhevelyuk specializes in oncology and radiology at Assuta Medical Center.
Dr. Lee Jihyeon is a breast and thyroid surgeon. He has expertise in benign and malignant breast diseases, oncoplastic breast surgery, and Mammotome biopsy. He also treats thyroid and parathyroid diseases. He practices pulmonary intensive care (critical care medicine).
He earned his M.D. from Yonsei University College of Medicine. He completed an internship and a general surgery residency at Yonsei University Severance Hospital. He also pursued a short-term fellowship at the Cancer Institute Hospital of JFCR in Japan.
His past roles include Chief of Surgery at Incheon Christian Hospital and Attending Surgeon at Cheil General Hospital. He served as Director of the Breast Center and as Chairman and Chief of Surgery at Samsung Cheil Hospital. He was Chairman of Surgery and Vice President of Medical Affairs at Cheil General Hospital. He also served as Clinical Professor of Surgery at Gangnam CHA Hospital, CHA University.
Dr. Park Sundo is a specialist in gastrointestinal and general surgery at Naeun Hospital. His expertise includes colorectal, proctology, breast, thyroid, laparoscopic, biliary, pancreatic, and pediatric surgery.
Key treatments include proctologic surgery, such as hemorrhoidectomy and care for hemorrhoids and anal fistula. He performs laparoscopic surgery for gallstones (cholelithiasis) and appendicitis. His oncology care covers gastric and colorectal cancer. He also performs hernia repair. Breast and thyroid care includes treatment of tumors and Mammotome biopsy. He treats varicose veins and severe burns. Pediatric surgery includes hernia repair and general pediatric procedures.
Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.
Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.
Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.
Assoc. Prof. Dr. Iyikesici specializes in metabolically supported chemotherapy – a tailored approach combining traditional methods with metabolic therapies at Central Hospital.
Dr. Eytan Aharon Ben-Ami leads the Oncology Division at Sheba Medical Center in Israel. He specialized in sarcoma and bone oncology at the Dana-Farber Cancer Institute. Dr. Ben-Ami founded the Sheba Clinical Research Organization to advance cancer studies. He treats rare bone tumors and soft tissue sarcomas with personalized protocols.
Prof. Ben Boursi leads research on microbiome prognostic factors in cancer therapies – merging cutting-edge science with clinical oncology at Sheba Medical Center.
Dr. Iris Kventsel is a pediatric hemato-oncologist and bone marrow transplant specialist at Sheba Medical Center. She treats childhood sarcomas like Ewing sarcoma and osteosarcoma at the Edmond and Lily Safra Children’s Hospital. Dr. Kventsel integrates targeted therapies with cellular treatments for complex childhood cancers. She serves on the academic staff at Tel Aviv University Faculty of Medicine.
Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.
Dr. Avichai Shimoni is the Director of Bone Marrow Transplantation at Sheba Medical Center. He treats complex blood cancers. He completed a specialized fellowship at the MD Anderson Cancer Center. Dr. Shimoni uses allogeneic and autologous transplants for high-risk patients. He is a professor and Chairman of Hematology at Tel Aviv University.
Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.
Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.
Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.
Dr. Ivetta Danylesko specializes in chemotherapy at Sheba Medical Center, bringing expert care tailored to individual patient needs.
Clinical Director of a Multidisciplinary Breast Unit with 322 peer-reviewed publications – Dr. Kuemmel leads breast cancer research at Kliniken Essen-Mitte.
With over 20 years of oncology expertise, Dr. Lucía González Cortijo leads Quironsalud Madrid's oncology department and specializes in breast and gynecologic cancers.